Tag: pruritus therapeutic market report

  • Pruritus Therapeutic Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Pruritus Therapeutic Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Growth Opportunities are Expected to Drive the Pruritus Therapeutic Market’s CAGR Through 2034?

    Significant growth has been observed in the pruritus therapeutic market size in the past few years. The market, which is predicted to be worth $14.29 billion in 2024, is projected to rise to $15.43 billion in 2025 with a 8.0% compound annual growth rate (CAGR). The growth during the previous period was driven by factors such as the rising incidence of pruritus, advancements in research and development, the growing elderly population, expanded healthcare infrastructures, heightened patient awareness, as well as collaborations and partnerships.

    The market for pruritus therapy is anticipated to witness substantial expansion over the next few years. Its financial scope is projected to reach $22.02 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%. Factors propelling growth during this forecast period include ongoing research and innovation, escalating healthcare spending, growth of emerging markets, the rise of personalized medicine, and regulatory encouragement of innovation. Key trends to watch within the forecast period encompass the integration of telemedicine and digital health, advancements in technology, adoption of telehealth and digital health solutions, the global regulatory environment, the use of biologics and immunomodulators, and the adoption of patient-focused strategies.

    What Drivers Are Shaping the Growth of the pruritus therapeutic Market?

    The escalating occurrence of skin-related conditions significantly fuels the expansion of pruritus therapeutics. These skin conditions, including acne, eczema, skin cancer, psoriasis, and vitiligo among others, typically have pruritus as a main symptom and hence, pruritus therapeutics becomes a vital part of treatment. For example, as per the American Academy of Dermatology Association in April 2022, it is estimated that melanoma will cause about 7,650 deaths this year, including 5,080 males and 2,570 females. Furthermore, projections by the American Cancer Society in January 2023 suggest that the United States will see approximately 97,610 new melanoma cases, split into about 58,120 in men and 39,490 in women. Thus, the rise in skin ailment cases will inevitably bolster the pruritus therapeutic market.

    Get Your Free Sample of the Global Pruritus Therapeutic Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

    What Are the Leading Industry Players Dominating the Pruritus Therapeutic Market?

    Major companies operating in the pruritus therapeutic market include:

    • Astellas Pharma Inc._x000D_

    • Bristol-Myers Squibb Company_x000D_

    • Cipla Inc._x000D_

    • Eli Lilly and Company_x000D_

    • Galderma Laboratories LP_x000D_

    What Are the Latest Trends Leading to Disruption in the Pruritus Therapeutic Market?

    The main trend gaining momentum in the pruritus therapeutic market is product innovation. A primary focus for major firms in this market is the creation of new medications and treatments for pruritus and related illnesses. To illustrate, Maruho Co., Ltd., a pharmaceutical company based in Japan, launched in August 2022, the first anti-IL-31 receptor, a humanized monoclonal antibody Mitchga Subcutaneous Injection 60 mg Syringes, aiming to treat itchiness caused by atopic dermatitis. This groundbreaking antibody drug works to inhibit IL-31 signaling, a neuroimmune cytokine2 that has been connected to pruritus and skin inflammation during the advancement of atopic dermatitis3,4. Its function is to block the IL-31 from connecting to its receptor, thus preventing itchiness and skin inflammation associated with atopic dermatitis.

    Get Instant Access to the Global Pruritus Therapeutic Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

    What Major Market Segments Define the Scope and Growth of the Pruritus Therapeutic Market?

    The pruritus therapeutic market covered in this report is segmented –

    1) By Type: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Others Types

    2) By Disease Type: Atopic Dermatitis Or Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

    3) By Application: External Use, Oral, Injection

    4) By End Use: Hospitals, Clinics, Other Uses

    Subsegments:

    1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

    2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

    3) By Local Anesthetics: Topical Local Anesthetics, Injectable Local Anesthetics

    4) By Counterirritants: Menthol-Based Products, Camphor-Based Products

    5) By Immunosuppressants: Systemic Immunosuppressants, Topical Immunosuppressants

    6) By Calcineurin Inhibitors: Tacrolimus, Pimecrolimus

    7) By Other Types: Antidepressants, Phototherapy Treatments, Herbal Remedies

    Which Regions Are Significant to the Growth of the Pruritus Therapeutic Market?

    North America was the largest region in the pruritus therapeutic market in 2024. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Can We Define the Pruritus Therapeutic Market and Its Key Components?

    Pruritus therapeutic refers to the treatment of pruritus which refer to the uncomfortable feeling that makes a person want to scratch. It can be caused by a variety of factors, which include contact with an allergen, dry skin, pregnancy, and the body’s reaction to a medicine.

    Browse Through More Similar Reports By The Business Research Company:

    Healthcare Cloud Computing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/healthcare-cloud-computing-global-market-report

    Healthcare Reimbursement Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

    Virtual Reality In Healthcare Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/virtual-reality-in-healthcare-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 2024-2033 Pruritus Therapeutic Market: Key Insights on Growth Opportunities

    2024-2033 Pruritus Therapeutic Market: Key Insights on Growth Opportunities

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Trajectory for the Pruritus Therapeutic Market by 2033?

    In the past few years, there has been a significant growth in the size of the pruritus therapeutic market. The market is projected to expand from a value of $13.1 billion in 2023 to $14.2 billion in 2024, achieving a compound annual growth rate (CAGR) of 8.4%. Various factors have contributed to the substantial growth during the historical period such as the increasing occurrences of pruritus, advancements in research and development, the rise in the aging population, broadening of healthcare infrastructure, a heightened awareness among patients, and collaborations or partnerships.

    In the coming years, the market size for pruritus therapeutics is predicted to witness robust expansion, increasing to $19.7 billion by 2028, with a compound annual growth rate (CAGR) of 8.5%. This anticipated surge during the forecast period is due to ongoing research and innovation, booming markets in developing countries, increased health care spending, the rise of personalized medicine, and favorable regulatory support for new inventions. Notably, the forecast period will also see emerging trends like telemedicine and the incorporation of digital health, technological enhancements, digital health and telehealth solutions, the dynamic global regulatory environment, biologics, immunomodulators, and approaches that center around patients.

    Claim Your Free Sample of the Global Pruritus Therapeutic Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

    What Factors Are Leading to Growth in the pruritus therapeutic Market?

    The rise in skin disease cases is playing a major role in the expansion of the pruritus therapeutic market. Skin conditions, such as acne, eczema, skin cancer, psoriasis, and vitiligo, are referred to as dermatological conditions that impact the skin. Pruritus therapeutics come into play in the treatment of various skin ailments because most of them have pruritus as the main symptom. For example, the American Academy of Dermatology Association states that as of April 2022, melanoma is anticipated to be responsible for 7,650 deaths this year, including 5,080 men and 2,570 women. Moreover, the American Cancer Society predicted in January 2023, that approximately 97,610 new melanoma cases will appear in the United States in 2023. This includes about 58,120 men and 39,490 women. As a result, the growth in skin disease cases will push the pruritus therapeutic market forward.

    Which Segments Play a Key Role in Understanding the Pruritus Therapeutic Market?

    1) By Type: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Others Types

    2) By Disease Type: Atopic Dermatitis Or Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

    3) By Application: External Use, Oral, Injection

    4) By End Use: Hospitals, Clinics, Other Uses

    What Trends Are Emerging as Game-Changers in the Pruritus Therapeutic Market?

    The rising trend within the pruritus therapeutic market is product innovation. Many leading companies within the market are focusing their efforts on creation and development of innovative drugs and treatments for pruritus and related conditions. For example, in August 2022, Maruho Co., Ltd., a pharmaceutical firm based in Japan, introduced an anti-IL-31 receptor, a human monoclonal antibody drug named Mitchga Subcutaneous Injection 60 mg Syringes for the treatment of itching caused by atopic dermatitis. This is the pioneering antibody drug that blocks IL-31 signalling which is a neuroimmune cytokine2 associated with pruritus and skin inflammation in the advancement of atopic dermatitis3,4. This substance prevents the binding of IL-31 to its receptor and suppresses the itching and skin inflammation that accompany atopic dermatitis.

    Order Now for Fast Delivery of Your Pruritus Therapeutic Market Report!

    https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

    Which Regions Are Setting the Pace for Pruritus Therapeutic Market Growth?

    North America was the largest region in the pruritus therapeutic market in 2023. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Pruritus Therapeutic Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the pruritus therapeutic market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Pruritus Therapeutic Market Include

    1. Pruritus Therapeutic Market Executive Summary

    2. Pruritus Therapeutic Market Segments

    3. Pruritus Therapeutic Market Size And Template Market Growth Rate

    4. Key Pruritus Therapeutic Market Trends

    5. Major Pruritus Therapeutic Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Pruritus Therapeutic Market

    26. Top Pruritus Therapeutic Companies

    27. Pruritus Therapeutic Market Opportunities And Strategies

    28. Pruritus Therapeutic Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Pruritus Therapeutic Market 2024

    5 Key Insights On The Pruritus Therapeutic Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Pruritus Therapeutic Global Market Report 2024, the pruritus therapeutic market is expected to show significant growth in the forecast period.

    The pruritus therapeutic market has witnessed robust growth in recent years, driven by various factors contributing to its expansion. From $13.1 billion in 2023, the market is projected to reach $14.2 billion in 2024, boasting a compound annual growth rate (CAGR) of 8.4%. This growth trajectory is attributed to the increasing prevalence of pruritus, advancements in research and development, a growing aging population, expanding healthcare infrastructure, heightened patient awareness, and strategic collaborations within the industry.

    Looking Ahead: Projections and Drivers

    Expectations for the pruritus therapeutic market remain optimistic, with strong growth anticipated in the coming years. Forecasts indicate a rise to $19.7 billion by 2028, with a compound annual growth rate (CAGR) of 8.5%. This growth is fueled by ongoing research and innovation, the emergence of new markets, increased healthcare spending, the trend towards personalized medicine, and regulatory support for innovative therapies. Key trends in the forecast period encompass telemedicine integration, technological advancements, global regulatory landscapes, and patient-centric approaches.

    View More On The Pruritus Therapeutic Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

    Rising Incidences Of Skin Disorders Propel Growth In The Pruritus Therapeutic Market

    The escalating incidences of skin disorders play a pivotal role in driving the growth of the pruritus therapeutic market. Skin conditions such as acne, eczema, psoriasis, and skin cancer affect millions worldwide, with pruritus often being a prominent symptom. The rising prevalence of melanoma and other skin cancers, as reported by esteemed organizations like the American Academy of Dermatology Association and the American Cancer Society, underscores the urgency for effective pruritus therapeutics. Market leaders such as Allergan PLC, Bristol-Myers Squibb Company, and Novartis AG are actively involved in addressing these healthcare challenges.

    Pioneering Product Developments Drive Momentum

    Product innovation stands as a hallmark trend in the pruritus therapeutic market, as companies strive to develop groundbreaking medications and treatments. Maruho Co., Ltd.’s introduction of the anti-IL-31 receptor demonstrates a significant advancement in treating itching associated with atopic dermatitis. Similarly, Ipsen’s strategic acquisition of Albireo Pharma, Inc. enriches its portfolio with therapies for pediatric liver disorders and pruritus, consolidating its position in the market. These initiatives underscore the industry’s commitment to innovation and improving patient outcomes.

    Exploring Market Segmentation and Regional Insights

    The pruritus therapeutic market is characterized by diverse segmentation based on type, disease type, application, and end-use. From corticosteroids to immunosuppressants, the market offers a wide array of treatment options catering to various skin conditions. North America emerges as the largest region in the pruritus therapeutic market, reflecting the region’s robust healthcare infrastructure and research capabilities.

    In conclusion, the pruritus therapeutic market presents substantial opportunities for growth and innovation. As stakeholders continue to invest in research, development, and strategic partnerships, the landscape of pruritus treatment is poised for transformation. With a focus on patient-centric approaches, technological advancements, and regulatory support, the future of pruritus therapeutics holds promise for addressing the evolving needs of patients worldwide.

    Request A Sample Of The Global Pruritus Therapeutic Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9925&type=smp